---
title: "TADVALKAR LAURA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/19515a4b-e95c-505f-8df3-c8f82437b419
json: https://whiteintel.dev/api/public/dossier/19515a4b-e95c-505f-8df3-c8f82437b419
identifier: sec:0002020464
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# TADVALKAR LAURA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002020464`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/19515a4b-e95c-505f-8df3-c8f82437b419  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/19515a4b-e95c-505f-8df3-c8f82437b419  

## Ownership & control

### Holdings / subsidiaries

- **HEMAB THERAPEUTICS HOLDINGS, INC.** (director) — https://whiteintel.dev/entity/9e165d1b-994a-5fc3-9fb5-032c0017644f
- **Cidara Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/390d0573-0eba-5945-9b14-d2e453caaa1d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **TADVALKAR LAURA**. Human view: https://whiteintel.dev/entity/19515a4b-e95c-505f-8df3-c8f82437b419 · Structured JSON: https://whiteintel.dev/api/public/dossier/19515a4b-e95c-505f-8df3-c8f82437b419._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._